Skip to content

Clinical trials

Phase 3 Schizophrenia trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 3 Country / region: Japan Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20082
20091
20105
20112
20123
20142
20213
20225
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting4
Terminated3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma Co., Ltd.6
Otsuka Pharmaceutical Co., Ltd.4
Boehringer Ingelheim3
Janssen Pharmaceutical K.K.3
Karuna Therapeutics, Inc., a Bristol Myers Squibb company3
Bristol-Myers Squibb2
Eli Lilly and Company2
Hoffmann-La Roche2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
AbbVie1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia31
Autistic Disorder1
Bipolar Disorder1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.